Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
23.95
+0.04 (0.17%)
Mar 18, 2026, 2:38 PM EDT - Market open
Tandem Diabetes Care Revenue
In the year 2025, Tandem Diabetes Care had annual revenue of $1.01B with 7.93% growth. Tandem Diabetes Care had revenue of $290.38M in the quarter ending December 31, 2025, with 2.74% growth.
Revenue (ttm)
$1.01B
Revenue Growth
+7.93%
P/S Ratio
1.61
Revenue / Employee
$405,894
Employees
2,500
Market Cap
1.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.01B | 74.53M | 7.93% |
| Dec 31, 2024 | 940.20M | 192.49M | 25.74% |
| Dec 31, 2023 | 747.72M | -53.50M | -6.68% |
| Dec 31, 2022 | 801.22M | 98.42M | 14.00% |
| Dec 31, 2021 | 702.80M | 203.97M | 40.89% |
| Dec 31, 2020 | 498.83M | 136.53M | 37.68% |
| Dec 31, 2019 | 362.31M | 178.44M | 97.05% |
| Dec 31, 2018 | 183.87M | 76.27M | 70.88% |
| Dec 31, 2017 | 107.60M | 23.35M | 27.72% |
| Dec 31, 2016 | 84.25M | 11.40M | 15.65% |
| Dec 31, 2015 | 72.85M | 23.13M | 46.51% |
| Dec 31, 2014 | 49.72M | 20.72M | 71.41% |
| Dec 31, 2013 | 29.01M | 26.53M | 1,072.00% |
| Dec 31, 2012 | 2.48M | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| QuidelOrtho | 2.73B |
| Enovis | 2.25B |
| Lumexa Imaging Holdings | 1.00B |
| Inspire Medical Systems | 911.98M |
| NovoCure | 655.35M |
| UFP Technologies | 602.80M |
| Artivion | 441.33M |
TNDM News
- 1 day ago - Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence - Benzinga
- 13 days ago - Tandem Mobi Now Compatible with Android Smartphones - Business Wire
- 19 days ago - Tandem Diabetes Care, Inc. (TNDM) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript - Seeking Alpha
- 21 days ago - Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032 - Business Wire
- 22 days ago - Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes - Business Wire
- 23 days ago - Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition - Seeking Alpha
- 26 days ago - Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook - Benzinga
- 26 days ago - Tandem Diabetes Care Analysts Boost Their Forecasts After Upbeat Q4 Results - Benzinga